Noga Shalev, Karen Brudney, Matthew Scherer
Abstract
To the Editor As HIV clinicians, we read with interest the new antiretroviral treatment guidelines published on behalf of the International Antiviral Society–USA.1 Nevertheless, we believe these guidelines failed to integrate emerging evidence and may have reflected implicit commercial bias.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the Editor As HIV clinicians, we read with interest the new antiretroviral treatment guidelines published on behalf of the International Antiviral Society–USA.1 Nevertheless, we believe these guidelines failed to integrate emerging evidence and may have reflected implicit commercial bias.
Key concepts: Medicine, Human immunodeficiency virus (HIV), Antiretroviral treatment, Antiretroviral drug, Antiretroviral therapy, ANTIRETROVIRAL AGENTS, Intensive care medicine, Drug